Roche NZ is based in Newmarket, Auckland where a team of 39 dedicated people have the goal of facilitating access to our innovative medicines.
With its parent company in Basel, Switzerland, our local company has serviced New Zealand for over 40 years and has supplied over 100 Roche medicines to New Zealanders.
Our clinical research team works closely with New Zealand’s clinical research experts. Currently Roche supports or sponsors approximately 40 clinical trials, making us one of the leading companies investing in medicines research in New Zealand. Our trials cover diseases including cancer (solid tumour types and cancers of the blood), multiple sclerosis, Huntington’s disease, haemophilia, and asthma.